Actively Recruiting
The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery
Led by Taichung Veterans General Hospital · Updated on 2024-02-21
150
Participants Needed
2
Research Sites
151 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to the dose effect of tranexamic acid and the level of ACT on bleeding in adult cardiac surgery. The main questions it aims to answer are: 1. Does higher dose of tranexamic acid reduce the amount of bleeding and blood transfusion? 2. Does lower ACT level during cardiac surgery reduce the amount of bleeding and blood transfusion? Participants will divided into four groups which have different tranexamic acid dose and ACT level during cardiac surgery to see if there is any different in the amount of bleeding and blood transfusion.
CONDITIONS
Official Title
The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients undergoing cardiac surgery with cardiopulmonary bypass
You will not qualify if you...
- Pregnant
- Emergency procedure
- Immune compromised
- Aortic surgery
- End-stage renal disease
- Liver disease
- Critical status
- Incomplete clinical data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Taichung Veterans General Hospital
Taichung, Taiwan, 40705
Actively Recruiting
2
Taichung Veterans General hospital
Taichung, Taiwan, 40705
Actively Recruiting
Research Team
Y
Yung-Szu Wu, MD
CONTACT
Y
Yi-Ting Chang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here